Clinical Trial

Prevention of Heart Failure in Type 2 Diabetes by Exercise Intervention

Study acronym: PROTECTION
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2024 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Global longitudinal strain emerged as an important predictive marker that could be assessed during echocardiography. It enabled the detection of subclinical myocardial systolic dysfunction, without observable reductions in cardiac output or left ventricular ejection fraction, often years before diabetes induced heart failure. In asymptomatic T2D patients with no history of cardiovascular disease, an impaired global longitudinal strain is a predictor of future adverse left ventricular remodeling and adverse cardiovascular events. Exercise training is a promising intervention to interfere in the diabetes induced heart failure pathophysiology. However, the impact of different exercise modalities (e.g. intensity and volume) on the global longitudinal strain in type 2 diabetes (T2D) is unknown.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-08-24; most recent amendment 2024-09-23.
Status change: Recruiting → Active, Not Recruiting 2024-09-23
Status change: Not Yet Recruiting → Recruiting 2024-03-14
Trial Details
NCT Number NCT05023538
Lead Sponsor Hasselt University
Collaborators: Jessa Hospital, KU Leuven, University Ghent
Conditions Type 2 Diabetes
Enrollment 182 participants
Start Date 2022-03-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-25